Encyclopedia of AIDS

Living Edition
| Editors: Thomas J. Hope, Douglas Richman, Mario Stevenson

Pregnant Women: Care and Treatment

Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-9610-6_254-1

Epidemiology of HIV/AIDS in Women

HIV/AIDS continues to be a major global cause of morbidity and mortality in women. In 2011, more than 50 % of the 34 million people infected with HIV were women (UNAIDS/WHO 2012). HIV/AIDS is the major cause of death in women of childbearing age (ages 15–49) in the developing world. The primary mode of HIV transmission in women in the United States and globally is heterosexual contact. In 2013, there were 24.7 million people living with HIV/AIDS in sub-Saharan Africa, the global region that accounts for approximately 70 % of HIV/AIDS cases, and 58 % of those were women. In the United States, women accounted for approximately 24 % of new diagnoses of AIDS in 2012 (Centers for Disease Control 2014), and there were over 270,000 women among the 1.1 million people living with HIV infection and AIDS in the United States as of 2013. With the increase in access to potent antiretroviral therapy (ART) in developing countries, the rates of perinatal infection...

Keywords

Alkaloid Lamivudine Zidovudine Ritonavir Mastitis 
This is a preview of subscription content, log in to check access

References

  1. Centers for Disease Control. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data – United States and 6 dependent areas – 2012. HIV Surveill Suppl Rep. 2014;19(3):1–61.Google Scholar
  2. Ciaranello AL, Perez F, Engelsmann B, et al. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis. 2013;56:430–46.CrossRefPubMedGoogle Scholar
  3. Cohn SE, Clark RA. Human immunodeficiency virus infection in women. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier; 2015.Google Scholar
  4. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173–80.CrossRefPubMedGoogle Scholar
  5. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585–8.CrossRefPubMedGoogle Scholar
  6. Fasawe O, Avila C, Shaffer N, et al. Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi. PLoS One. 2013;8:e57778.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Ford N, Calmy A, Mofenson L. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS. 2011;25:2301–4.CrossRefPubMedGoogle Scholar
  8. Ford N, Calmy A, Andrieux-Meyer I, Hargreaves S, Mills EJ, Shubber Z. Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. AIDS. 2013;27:1135–43.CrossRefPubMedGoogle Scholar
  9. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802.CrossRefPubMedGoogle Scholar
  10. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis. 1997;175:172–5.CrossRefPubMedGoogle Scholar
  11. O’Brien L, Shaffer N, Sangrujee N, Abimbola TO. The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV. Bull World Health Organ. 2014;92:162–70.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2014. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed 15 Feb 2015.
  13. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996;335:1621–9.CrossRefPubMedGoogle Scholar
  14. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med. 1999;340:977–87.Google Scholar
  15. UNAIDS. Countdown to zero: global plan for the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011–2015. Geneva: UNAIDS; 2011.Google Scholar
  16. UNAIDS/WHO. UNAIDS report on the global AIDS epidemic 2012. 2012. Available at http://www.unaids.org/en/media/unaids/contentassests/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf. Accessed 15 Feb 2015.
  17. Van de Perre P, Simonon A, Msellati P, et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med. 1991;325:593–8.CrossRefPubMedGoogle Scholar
  18. WHO/UNICEF. Guidelines on HIV and infant feeding. 2010. Available at http://www.unicef.org/nutrition/files/HIV_and_IF_guidelines_and_summary_of_evidence_2010.pdf. Accessed 15 Feb 2015.
  19. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2010. Available at http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf?ua=1. Accessed 15 Feb 2015.
  20. World Health Organization. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2012. Available at www.who.int/hiv/PMTCT_update.pdf. Accessed 15 Feb 2015.
  21. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2013. Available at http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1. Accessed 15 Feb 2015.

Copyright information

© Springer Science+Business Media LLC 2016

Authors and Affiliations

  1. 1.Division of Infectious DiseasesVanderbilt University Medical CenterNashvilleUSA